Net Income (Quarterly) Chart

View Net Income (Quarterly) for AAGH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income (Quarterly) Chart
Start Trial

Historical Net Income (Quarterly) Data

View and export this data back to 2011. Start Trial.
Date Value
March 31, 2026 -0.1662M
December 31, 2025 1.113M
September 30, 2025 -0.0854M
June 30, 2025 -0.2222M
March 31, 2025 -0.1584M
December 31, 2024 -0.1937M
September 30, 2024 -0.147M
June 30, 2024 -0.5915M
March 31, 2024 -0.2285M
December 31, 2023 -0.2493M
September 30, 2023 -0.157M
June 30, 2023 -0.2428M
March 31, 2023 -0.2136M
December 31, 2022 -0.1281M
September 30, 2022 -0.1928M
March 31, 2022 -0.6095M
December 31, 2021 -1.801M
September 30, 2021 -0.3313M
June 30, 2021 -0.1809M
March 31, 2021 -0.0492M
December 31, 2020 -0.0363M
September 30, 2020 -0.0027M
June 30, 2020 -0.0339M
March 31, 2020 -0.0027M
December 31, 2019 -0.0112M
Date Value
September 30, 2019 -0.0041M
June 30, 2019 -0.0133M
March 31, 2019 -0.0075M
December 31, 2018 -0.0365M
September 30, 2018 -0.0076M
June 30, 2018 -0.0215M
March 31, 2018 -0.0091M
December 31, 2017 -0.0151M
September 30, 2017 -0.0137M
June 30, 2017 -0.0362M
March 31, 2017 -0.0121M
December 31, 2016 -0.8607M
September 30, 2016 0.00
June 30, 2016 0.00
March 31, 2016 0.00
December 31, 2015 -0.115M
September 30, 2015 -0.693M
June 30, 2015 -0.1829M
March 31, 2015 -0.1588M
December 31, 2014 -0.1596M
September 30, 2014 -0.1588M
June 30, 2014 -0.1517M
March 31, 2014 -0.1517M
December 31, 2013 -0.0499M
September 30, 2013 -0.0221M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (Quarterly) Range, Past 5 Years

View Net Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Quarterly) Benchmarks

View Net Income (Quarterly) Benchmarks
Start Trial
AbbVie, Inc. 3.604B
Abeona Therapeutics, Inc. -20.19M
Acumen Pharmaceuticals, Inc. -32.72M
Abpro Holdings, Inc. -0.94M
Aardvark Therapeutics, Inc. -14.39M

Net Income (Quarterly) Related Metrics